TG Therapeutics, Inc.
TGTX
$48.74
$0.801.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.78M | 19.78M | 23.04M | 390.90M | 28.19M |
| Total Depreciation and Amortization | 53.00K | 32.00K | 21.00K | 17.00K | 13.00K |
| Total Amortization of Deferred Charges | 290.00K | 333.00K | 350.00K | 349.00K | 350.00K |
| Total Other Non-Cash Items | 28.07M | 31.73M | 40.80M | -349.70M | 15.63M |
| Change in Net Operating Assets | 3.07M | -69.76M | -44.54M | -64.71M | -36.74M |
| Cash from Operations | 39.26M | -17.89M | 19.66M | -23.15M | 7.44M |
| Capital Expenditure | -293.00K | -51.00K | -67.00K | -80.00K | -42.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.32M | -9.81M | -15.57M | 46.44M | -3.95M |
| Cash from Investing | 1.03M | -9.86M | -15.64M | 46.36M | -3.99M |
| Total Debt Issued | 0.00 | 747.66M | -- | -- | -- |
| Total Debt Repaid | 0.00 | -255.00M | -- | -- | -- |
| Issuance of Common Stock | 85.00K | 763.00K | 1.06M | 0.00 | 432.00K |
| Repurchase of Common Stock | 0.00 | -99.99M | 0.00 | -78.24M | -6.88M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -2.60M | -- | -- | -- |
| Cash from Financing | 85.00K | 390.83M | 1.06M | -78.24M | -6.44M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.38M | 363.07M | 5.08M | -55.03M | -3.00M |